United Scientific Group and the organizing committee members of Drug Discovery-2020 ensures a rigorous, high-quality and unbiased peer review process for all abstracts submitted to the conference. The decision of abstract acceptance will be judged by a panel of expert reviewers and/or session chair and/or conference chairman emphasizing whether the findings and/or conclusions are novel and make useful contributions to the field.
The committee will determine whether the abstract is more appropriate for oral or poster presentation. Eligibility for oral or poster presentation will be determined by the total score (with adjustment for differential scoring behavior between referees).
The committee operates a single/double-blind peer review process for all the abstracts submitted, where both the reviewer and the author remain anonymous.
The following are the steps that each abstract of Drug Discovery-2020 undergoes during the process of peer review:
Abstracts submitted by invited and/or keynote speakers will be reviewed by conference chairman.
Criteria to be Considered for Scoring
The abstract should be reviewed according to the following criteria: